4
Changes in Ownership
IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-015557
CMO,SVP,Head-Res&Drug sold 38,618 shares at $15.24 ($588,538)
- CMO,SVP,Head-Res&Drug acquired 54,427 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shetzline Michael CMO,SVP,Head-Res&Drug | 2024-02-12 | Sale | −38,618 | $15.24 | $588,538 | 340,484 | D |
| Shetzline Michael CMO,SVP,Head-Res&Drug | 2024-02-12 | Grant or award | +54,427 | 394,911 | D | ||
| Derivatives | |||||||
| Shetzline Michael CMO,SVP,Head-Res&Drug | 2024-02-12 | Grant or award · Performance-based Restricted Stock Unit | +27,214 | 27,214 | D | ||
| Open-market sales · 38,618 sh · avg $15.24 · $588,538 | |||||||
Loading xslF345X05/ownership.xml…